within Pharmacolibrary.Drugs.ATC.N;

model N06AA01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 2.0666666666666666e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0115,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0205,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.027899999999999998,
    k12             = 4.58,
    k21             = 4.58
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06AA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Desipramine is a tricyclic antidepressant (TCA) primarily used to treat major depressive disorder. It acts mainly as a norepinephrine reuptake inhibitor. While it has been largely replaced by newer antidepressants, desipramine is still approved and in use for depression and sometimes off-label for neuropathic pain and attention-deficit hyperactivity disorder (ADHD).</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics in healthy adult volunteers (mixed sex), oral administration.</p><h4>References</h4><ol><li><p>Nichols, AI, et al., &amp; Paul, J (2013). Effects of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults. <i>International clinical psychopharmacology</i> 28(2) 99–105. DOI:<a href=\"https://doi.org/10.1097/YIC.0b013e32835c1f49\">10.1097/YIC.0b013e32835c1f49</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23221858/\">https://pubmed.ncbi.nlm.nih.gov/23221858</a></p></li><li><p>Daniel, W, &amp; Melzacka, M (1992). A comparative study on desipramine pharmacokinetics in the rat brain after administration of desipramine or imipramine. <i>The Journal of pharmacy and pharmacology</i> 44(5) 429–432. DOI:<a href=\"https://doi.org/10.1111/j.2042-7158.1992.tb03638.x\">10.1111/j.2042-7158.1992.tb03638.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1359059/\">https://pubmed.ncbi.nlm.nih.gov/1359059</a></p></li><li><p>Harris, RZ, et al., &amp; Padhi, D (2007). Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl. <i>European journal of clinical pharmacology</i> 63(2) 159–163. DOI:<a href=\"https://doi.org/10.1007/s00228-006-0129-8\">10.1007/s00228-006-0129-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16680561/\">https://pubmed.ncbi.nlm.nih.gov/16680561</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06AA01;
